Home » Archives for September 1, 2021
September 1, 2021
RECENT POSTS
ADVERTISEMENT
SIMBA Chain Raises $25 Million in Series A Funding
South Bend, IN, Sept. 01, 2021 (GLOBE NEWSWIRE) — (via Blockchain Wire) SIMBA Chain, the technology company that has eliminated the complexities of blockchain app development and reduced energy usage thus opening the door to a world of users, has closed a $25 million Series A funding round led by Valley Capital
Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma
SHANGHAI, China and REDWOOD CITY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (“Coherus”, Nasdaq: CHRS) announced today the completion of the rolling submission of the Biologics License Application (“BLA”) to the U.S. Food and Drug
Philips starts repair and replacement program of first-generation DreamStation devices in the US in relation to earlier announced recall notification*
September 1, 2021Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced an update in connection with the June 14, 2021 recall notification* for specific Philips sleep and respiratory care devices that was issued to address potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam
Kava Swap Lists on AscendEX
Singapore, Aug. 31, 2021 (GLOBE NEWSWIRE) — AscendEX, a global digital asset trading platform with a comprehensive product suite, is thrilled to announce the listing of the Kava Swap token (SWP) under the pair USDT/SWP on September 1st at 1 p.m. UTC. Kava is focused on democratizing financial services and
Nyxoah Issues First Half 2021 Financial Results
REGULATED INFORMATION Nyxoah Issues First Half 2021 Financial Results Mont-Saint-Guibert, Belgium – August 31, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced